Original paper
Entecavir Induced Severe Myopathy: An Uncommon Side Effect
Volume: 2, Issue: 1, Pages: 15 - 17
Published: Apr 6, 2021
Abstract
Chronic Hepatitis B virus (HBV) infection is a chronic viral illness that affects millions of people around the world and can cause serious consequences such as hepatic failure and hepatocellular carcinoma.Entecavir, a guanosine nucleoside analog (NA), is a commonly used and generally safe therapeutic agent in HBV infection.In this paper, we aimed to present a case of chronic HBV that developed severe myopathy as an extremely rare side effect...
Paper Details
Title
Entecavir Induced Severe Myopathy: An Uncommon Side Effect
Published Date
Apr 6, 2021
Volume
2
Issue
1
Pages
15 - 17
References
No data available